Comparison between Bio Medica Laboratories IPO and Sihora Industries IPO.
Bio Medica Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sihora Industries IPO is a SME Fixed Price proposed to list at BSE SME.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Sobhagya Capital Options Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Aftertrade Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | ||
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Bio Medica Laboratories IPO is up to ₹0.00 Cr whereas the issue size of the Sihora Industries IPO is up to ₹10.03 Cr. The final issue price of Bio Medica Laboratories IPO is and of Sihora Industries IPO is ₹66.00 per share.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹66.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | |
| Fresh Issue Size | 32,05,200 shares | 15,20,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹10.03 Cr |
| OFS Issue Size | 3,76,800 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,82,000 shares | 15,20,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹10.03 Cr |
Bio Medica Laboratories IPO opens on , while Sihora Industries IPO opens on Oct 10, 2025. The closing date of Bio Medica Laboratories IPO and Sihora Industries IPO is , and Oct 14, 2025, respectively.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Oct 10, 2025 | |
| Issue Close | Oct 14, 2025 | |
| Basis Of Allotment (Tentative) | Oct 15, 2025 | |
| Initiation of Refunds (Tentative) | Oct 16, 2025 | |
| Credit of Share (Tentative) | Oct 16, 2025 | |
| Listing date (Tentative) | Oct 17, 2025 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bio Medica Laboratories IPO P/E ratio is , as compared to Sihora Industries IPO P/E ratio of 13.14.
| Bio Medica Laboratories IPO | Sihora Industries IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Bio Medica Laboratories Ltd.'s revenue increased by 150% and profit after tax (PAT) rose by 292% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Sihora Industries Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 214% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹35.16 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 99.59 | 35.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 48.20 | 31.93 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.02 | 0.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 99.59 | 35.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 0 shares while in Sihora Industries IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Bio Medica Laboratories IPO and 0 shares in Sihora Industries IPO.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,89,600 shares | 80,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 7,60,000 shares |
| RII | 0 shares | 7,60,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 15,20,000 shares |
Bio Medica Laboratories IPO subscribed in total, whereas Sihora Industries IPO subscribed 1.27x.
| Bio Medica Laboratories IPO | Sihora Industries IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.18x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.37x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.27x |
